Cargando…

Association of a Lay Health Worker Intervention With Symptom Burden, Survival, Health Care Use, and Total Costs Among Medicare Enrollees With Cancer

IMPORTANCE: Undertreated patient symptoms require approaches that improve symptom burden. OBJECTIVE: To determine the association of a lay health worker–led symptom screening and referral intervention with symptom burden, survival, health care use, and total costs among Medicare Advantage enrollees...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Manali I., Ramirez, David, Agajanian, Richy, Agajanian, Hilda, Coker, Tumaini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076340/
https://www.ncbi.nlm.nih.gov/pubmed/32176306
http://dx.doi.org/10.1001/jamanetworkopen.2020.1023
_version_ 1783507195546042368
author Patel, Manali I.
Ramirez, David
Agajanian, Richy
Agajanian, Hilda
Coker, Tumaini
author_facet Patel, Manali I.
Ramirez, David
Agajanian, Richy
Agajanian, Hilda
Coker, Tumaini
author_sort Patel, Manali I.
collection PubMed
description IMPORTANCE: Undertreated patient symptoms require approaches that improve symptom burden. OBJECTIVE: To determine the association of a lay health worker–led symptom screening and referral intervention with symptom burden, survival, health care use, and total costs among Medicare Advantage enrollees with a new diagnosis of solid or hematologic malignant neoplasms. DESIGN, SETTING, AND PARTICIPANTS: This quality improvement study conducted at 9 community oncology practices from November 1, 2016, to October 31, 2018, compared newly diagnosed Medicare Advantage enrollees with solid or hematologic malignant neoplasms with patients diagnosed and treated 1 year prior. Analysis was conducted from August 1, 2019, to January 11, 2020. INTERVENTIONS: Usual care augmented by a lay health worker trained to screen symptoms and refer patients to palliative care and behavioral medicine. MAIN OUTCOMES AND MEASURES: The primary outcome was change in symptoms using the Edmonton Symptom Assessment Scale and the 9-item Patient Health Questionnaire at baseline and 6 and 12 months after enrollment. Secondary outcomes were between-group comparison of survival, 12-month health care use, and costs. RESULTS: Among 425 patients in the intervention group and 407 patients in the control group, the mean (SD) age was 78.8 (8.3) years, 345 (41.5%) were female, and 407 (48.9%) were non-Hispanic white. Patients in the intervention group experienced a lower symptom burden as measured by the Edmonton Symptom Assessment Scale score over time compared with patients in the control group (mean [SD] difference, −1.9 [14.2]; 95% CI, −3.77 to −0.19; P = .01 for the intervention group and 2.32 [17.7]; 95% CI, 0.47 to 4.19; P = .02 for the control group). Similar findings were noted in 9-item Patient Health Questionnaire depression scores (mean [SD] difference, −0.63 [3.99]; 95% CI, −1.23 to −0.028; P = .04 for the intervention group and 1.67 [5.49]; 95% CI, 0.95 to 2.37; P = .01 for the control group). Patients in the intervention group compared with patients in the control group had fewer mean (SD) inpatient visits (0.54 [0.77]; 95% CI, 0.47-0.61 vs 0.72 [1.12]; 95% CI, 0.61-0.83; P = .04) and emergency department visits (0.43 [0.76]; 95% CI, 0.36-0.50 vs 0.57 [1.00]; 95% CI, 0.48-0.67; P = .002) per 1000 patients per year and lower total costs (median, $17 869 [interquartile range, $6865-$32 540] vs median, $18 473 [interquartile range, $6415-$37 910]; P = .02). A total of 180 patients in the intervention group and 189 patients in the control group died within 12 months. Among those who died, patients in the intervention group had greater hospice use (125 of 180 [69.4%] vs 79 of 189 [41.8%]; odds ratio, 3.16; 95% CI, 2.13-4.69; P < .001), fewer mean (SD) emergency department and hospital visits (emergency department: 0.10 [0.30]; 95% CI, 0.06-0.14 vs 0.30 [0.46]; 95% CI, 0.24-0.38; P = .001; hospital: 0.27 [0.44]; 95% CI, 0.21-0.34 vs 0.43 [0.82]; 95% CI, 0.32-0.55; P = .02), and lower costs (median, $3602 [interquartile range, $1076-$9436] vs median, $12 726 [interquartile range, $5259-$22 170]; P = .002), but there was no significant difference in inpatient deaths (18 of 180 [10.0%] vs 30 of 189 [15.9%]; P = .14). CONCLUSIONS AND RELEVANCE: This study suggests that a lay health worker–led intervention may be one way to improve burdensome and costly care.
format Online
Article
Text
id pubmed-7076340
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-70763402020-03-19 Association of a Lay Health Worker Intervention With Symptom Burden, Survival, Health Care Use, and Total Costs Among Medicare Enrollees With Cancer Patel, Manali I. Ramirez, David Agajanian, Richy Agajanian, Hilda Coker, Tumaini JAMA Netw Open Original Investigation IMPORTANCE: Undertreated patient symptoms require approaches that improve symptom burden. OBJECTIVE: To determine the association of a lay health worker–led symptom screening and referral intervention with symptom burden, survival, health care use, and total costs among Medicare Advantage enrollees with a new diagnosis of solid or hematologic malignant neoplasms. DESIGN, SETTING, AND PARTICIPANTS: This quality improvement study conducted at 9 community oncology practices from November 1, 2016, to October 31, 2018, compared newly diagnosed Medicare Advantage enrollees with solid or hematologic malignant neoplasms with patients diagnosed and treated 1 year prior. Analysis was conducted from August 1, 2019, to January 11, 2020. INTERVENTIONS: Usual care augmented by a lay health worker trained to screen symptoms and refer patients to palliative care and behavioral medicine. MAIN OUTCOMES AND MEASURES: The primary outcome was change in symptoms using the Edmonton Symptom Assessment Scale and the 9-item Patient Health Questionnaire at baseline and 6 and 12 months after enrollment. Secondary outcomes were between-group comparison of survival, 12-month health care use, and costs. RESULTS: Among 425 patients in the intervention group and 407 patients in the control group, the mean (SD) age was 78.8 (8.3) years, 345 (41.5%) were female, and 407 (48.9%) were non-Hispanic white. Patients in the intervention group experienced a lower symptom burden as measured by the Edmonton Symptom Assessment Scale score over time compared with patients in the control group (mean [SD] difference, −1.9 [14.2]; 95% CI, −3.77 to −0.19; P = .01 for the intervention group and 2.32 [17.7]; 95% CI, 0.47 to 4.19; P = .02 for the control group). Similar findings were noted in 9-item Patient Health Questionnaire depression scores (mean [SD] difference, −0.63 [3.99]; 95% CI, −1.23 to −0.028; P = .04 for the intervention group and 1.67 [5.49]; 95% CI, 0.95 to 2.37; P = .01 for the control group). Patients in the intervention group compared with patients in the control group had fewer mean (SD) inpatient visits (0.54 [0.77]; 95% CI, 0.47-0.61 vs 0.72 [1.12]; 95% CI, 0.61-0.83; P = .04) and emergency department visits (0.43 [0.76]; 95% CI, 0.36-0.50 vs 0.57 [1.00]; 95% CI, 0.48-0.67; P = .002) per 1000 patients per year and lower total costs (median, $17 869 [interquartile range, $6865-$32 540] vs median, $18 473 [interquartile range, $6415-$37 910]; P = .02). A total of 180 patients in the intervention group and 189 patients in the control group died within 12 months. Among those who died, patients in the intervention group had greater hospice use (125 of 180 [69.4%] vs 79 of 189 [41.8%]; odds ratio, 3.16; 95% CI, 2.13-4.69; P < .001), fewer mean (SD) emergency department and hospital visits (emergency department: 0.10 [0.30]; 95% CI, 0.06-0.14 vs 0.30 [0.46]; 95% CI, 0.24-0.38; P = .001; hospital: 0.27 [0.44]; 95% CI, 0.21-0.34 vs 0.43 [0.82]; 95% CI, 0.32-0.55; P = .02), and lower costs (median, $3602 [interquartile range, $1076-$9436] vs median, $12 726 [interquartile range, $5259-$22 170]; P = .002), but there was no significant difference in inpatient deaths (18 of 180 [10.0%] vs 30 of 189 [15.9%]; P = .14). CONCLUSIONS AND RELEVANCE: This study suggests that a lay health worker–led intervention may be one way to improve burdensome and costly care. American Medical Association 2020-03-16 /pmc/articles/PMC7076340/ /pubmed/32176306 http://dx.doi.org/10.1001/jamanetworkopen.2020.1023 Text en Copyright 2020 Patel MI et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Patel, Manali I.
Ramirez, David
Agajanian, Richy
Agajanian, Hilda
Coker, Tumaini
Association of a Lay Health Worker Intervention With Symptom Burden, Survival, Health Care Use, and Total Costs Among Medicare Enrollees With Cancer
title Association of a Lay Health Worker Intervention With Symptom Burden, Survival, Health Care Use, and Total Costs Among Medicare Enrollees With Cancer
title_full Association of a Lay Health Worker Intervention With Symptom Burden, Survival, Health Care Use, and Total Costs Among Medicare Enrollees With Cancer
title_fullStr Association of a Lay Health Worker Intervention With Symptom Burden, Survival, Health Care Use, and Total Costs Among Medicare Enrollees With Cancer
title_full_unstemmed Association of a Lay Health Worker Intervention With Symptom Burden, Survival, Health Care Use, and Total Costs Among Medicare Enrollees With Cancer
title_short Association of a Lay Health Worker Intervention With Symptom Burden, Survival, Health Care Use, and Total Costs Among Medicare Enrollees With Cancer
title_sort association of a lay health worker intervention with symptom burden, survival, health care use, and total costs among medicare enrollees with cancer
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7076340/
https://www.ncbi.nlm.nih.gov/pubmed/32176306
http://dx.doi.org/10.1001/jamanetworkopen.2020.1023
work_keys_str_mv AT patelmanalii associationofalayhealthworkerinterventionwithsymptomburdensurvivalhealthcareuseandtotalcostsamongmedicareenrolleeswithcancer
AT ramirezdavid associationofalayhealthworkerinterventionwithsymptomburdensurvivalhealthcareuseandtotalcostsamongmedicareenrolleeswithcancer
AT agajanianrichy associationofalayhealthworkerinterventionwithsymptomburdensurvivalhealthcareuseandtotalcostsamongmedicareenrolleeswithcancer
AT agajanianhilda associationofalayhealthworkerinterventionwithsymptomburdensurvivalhealthcareuseandtotalcostsamongmedicareenrolleeswithcancer
AT cokertumaini associationofalayhealthworkerinterventionwithsymptomburdensurvivalhealthcareuseandtotalcostsamongmedicareenrolleeswithcancer